Hribernik N, Strašek K, Studen A, Zevnik K, Škalič K, Jeraj R, et al. Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy. Radiol Oncol [Internet]. 2025 Feb. 25 [cited 2026 Jun. 14];59(1):43-5. Available from: https://www.radioloncol.com/index.php/ro/article/view/4548